Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multi-centre Randomised Double Blinded Phase III Trial of the Effect of Standard Issue Red Blood Cell Blood Units on Mortality Compared to Freshest Available Red Blood Cell Units

NCT01638416 is registered in ClinicalTrials.gov with Australian and New Zealand Intensive Care Research Centre as lead sponsor.

NCT NCT01638416
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01638416 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multi-centre Randomised Double Blinded Phase III Trial of the Effect of Standard Issue Red Blood Cell Blood Units on Mortality Compared to Freshest Available Red Blood Cell Units
Lead sponsor
Australian and New Zealand Intensive Care Research Centre
Phase
Phase 3
Overall status
Completed
Start date
October 31, 2012
Completion date
June 30, 2017
Enrollment
4,994 (actual)
Sites
60

Conditions

As the registry lists them; a condition with its own page is linked.

age of blood, transfusion